Moshe Hoshen

4.0k total citations · 2 hit papers
66 papers, 2.0k citations indexed

About

Moshe Hoshen is a scholar working on Epidemiology, Public Health, Environmental and Occupational Health and Infectious Diseases. According to data from OpenAlex, Moshe Hoshen has authored 66 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Epidemiology, 16 papers in Public Health, Environmental and Occupational Health and 10 papers in Infectious Diseases. Recurrent topics in Moshe Hoshen's work include Malaria Research and Control (12 papers), Mosquito-borne diseases and control (7 papers) and Pneumonia and Respiratory Infections (6 papers). Moshe Hoshen is often cited by papers focused on Malaria Research and Control (12 papers), Mosquito-borne diseases and control (7 papers) and Pneumonia and Respiratory Infections (6 papers). Moshe Hoshen collaborates with scholars based in Israel, United States and United Kingdom. Moshe Hoshen's co-authors include Andrew P. Morse, Ran D. Balicer, H. Ginsburg, Wilfred D. Stein, Becca Feldman, Setor K. Kunutsor, Cristina Pellegrino Baena, Oscar H. Franco, An Pan and Hassan Khan and has published in prestigious journals such as New England Journal of Medicine, PLoS ONE and PEDIATRICS.

In The Last Decade

Moshe Hoshen

65 papers receiving 2.0k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Vitamin D and risk of cause specific death: systematic review and meta-analysis of observational cohort and randomised intervention studies

2014 458 citations Rajiv Chowdhury, Setor K. Kunutsor et al. BMJ profile →
Nirmatrelvir Use and Severe Covid-19 Outcomes during the Omicron Surge

2022 197 citations Moshe Hoshen, Ran D. Balicer et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Moshe Hoshen Israel	22	724	385	317	268	241	66	2.0k
Enju Liu United States	25	385 0.5×	373 1.0×	440 1.4×	379 1.4×	551 2.3×	105	1.9k
Paul Arora Canada	24	308 0.4×	196 0.5×	417 1.3×	526 2.0×	178 0.7×	67	2.3k
Patricia Priest New Zealand	21	424 0.6×	174 0.5×	253 0.8×	237 0.9×	152 0.6×	68	1.5k
Ashish Bhalla India	34	409 0.6×	309 0.8×	456 1.4×	896 3.3×	56 0.2×	231	3.9k
Yingdong Zheng China	17	338 0.5×	190 0.5×	459 1.4×	455 1.7×	318 1.3×	41	1.9k
Chien‐Yu Lin Taiwan	31	232 0.3×	151 0.4×	500 1.6×	334 1.2×	263 1.1×	134	2.9k
Anne C. M. Thiébaut France	27	611 0.8×	238 0.6×	176 0.6×	578 2.2×	309 1.3×	69	2.5k
Kurt Z. Long Switzerland	23	357 0.5×	145 0.4×	276 0.9×	189 0.7×	652 2.7×	64	1.7k
Denis Malvy France	23	1.3k 1.7×	133 0.3×	741 2.3×	333 1.2×	521 2.2×	49	2.8k
Priyaleela Thota United States	20	269 0.4×	181 0.5×	872 2.8×	610 2.3×	90 0.4×	46	2.1k

Countries citing papers authored by Moshe Hoshen

Since Specialization

Citations

This map shows the geographic impact of Moshe Hoshen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Moshe Hoshen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Moshe Hoshen more than expected).

Fields of papers citing papers by Moshe Hoshen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Moshe Hoshen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Moshe Hoshen. The network helps show where Moshe Hoshen may publish in the future.

Co-authorship network of co-authors of Moshe Hoshen

This figure shows the co-authorship network connecting the top 25 collaborators of Moshe Hoshen. A scholar is included among the top collaborators of Moshe Hoshen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Moshe Hoshen. Moshe Hoshen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Giladi, Hilla, Meytal Avgil Tsadok, Dekel Shlomi, et al.. (2022). Postexposure‐vaccine‐prophylaxis against COVID‐19. Journal of Medical Virology. 95(1). 2 indexed citations

Srulovici, Einav, Maya Leventer‐Roberts, Bradley Curtis, et al.. (2020). Long‐term effectiveness of the Diabetes Conversation Map™ Program on health outcomes: A case–control retrospective cohort study. Journal of Advanced Nursing. 76(9). 2299–2310. 3 indexed citations

Flaks‐Manov, Natalie, Maxim Topaz, Moshe Hoshen, Ran D. Balicer, & Efrat Shadmi. (2019). Identifying patients at highest-risk: the best timing to apply a readmission predictive model. BMC Medical Informatics and Decision Making. 19(1). 118–118. 12 indexed citations

Spitzer, Sivan, Efrat Shadmi, Margalit Goldfracht, et al.. (2018). Evaluating an organization-wide disparity reduction program: Understanding what works for whom and why. PLoS ONE. 13(3). e0193179–e0193179. 5 indexed citations

Benis, Arriel & Moshe Hoshen. (2017). DisEpi: Compact Visualization as a Tool for Applied Epidemiological Research. Studies in health technology and informatics. 244. 38–42. 1 indexed citations

Leventer‐Roberts, Maya, Ariel Hammerman, Moshe Hoshen, et al.. (2017). Effectiveness of dasabuvir/ombitasvir/paritaprevir/ritonavir for hepatitis C virus in clinical practice: A population-based observational study. PLoS ONE. 12(7). e0176858–e0176858. 7 indexed citations

Cohen, Herman Avner, et al.. (2016). Seasonality of Methylphenidate Administration among Children in Israel.. PubMed. 18(11). 655–660. 4 indexed citations

Cohen, Herman Avner, et al.. (2016). Efficacy and tolerability of a polysaccharide-resin-honey based cough syrup as compared to carbocysteine syrup for children with colds: a randomized, single-blinded, multicenter study. World Journal of Pediatrics. 13(1). 27–33. 27 indexed citations

Tonkikh, Orly, Efrat Shadmi, Natalie Flaks‐Manov, et al.. (2016). Functional status before and during acute hospitalization and readmission risk identification. Journal of Hospital Medicine. 11(9). 636–641. 45 indexed citations

10.

Spitzer, Sivan, et al.. (2016). Reducing inequity in primary care clinics treating low socioeconomic Jewish and Arab populations in Israel. Journal of Public Health. 39(2). fdw037–fdw037. 5 indexed citations

11.

Leventer‐Roberts, Maya, et al.. (2015). Effectiveness of 23-Valent Pneumococcal Polysaccharide Vaccine Against Invasive Disease and Hospital-Treated Pneumonia Among People Aged ≥65 Years: A Retrospective Case-Control Study. Clinical Infectious Diseases. 60(10). 1472–1480. 43 indexed citations

12.

Chowdhury, Rajiv, Setor K. Kunutsor, Anna Vitezova, et al.. (2014). Vitamin D and risk of cause specific death: systematic review and meta-analysis of observational cohort and randomised intervention studies. BMJ. 348(apr01 2). g1903–g1903. 458 indexed citations breakdown →

13.

Gavrielov‐Yusim, Natalie, Moshe Hoshen, Shepherd Roee Singer, Lily Neumann, & Ran D. Balicer. (2014). The weight of MMRV-related febrile convulsions among other clinical factors contributing to febrile convulsions in children. Vaccine. 32(39). 4954–4959. 11 indexed citations

14.

Balicer, Ran D., et al.. (2014). Pneumococcal vaccine targeting strategy for older adults: Customized risk profiling. Vaccine. 32(8). 990–995. 2 indexed citations

15.

Calderon‐Margalit, Ronit, et al.. (2007). Dialysis in Israel, 1989-2005--time trends and international comparisons. Nephrology Dialysis Transplantation. 23(2). 659–664. 14 indexed citations

16.

Sauerborn, Rainer, et al.. (2007). Using modelling to assess the risk of malarial infection during the dry season, on a local scale in an endemic area of rural Burkina Faso. Annals of Tropical Medicine and Parasitology. 101(5). 375–389. 4 indexed citations

17.

Yé, Yazoume, Moshe Hoshen, Valérie R. Louis, et al.. (2006). Housing conditions and Plasmodium falciparum infection: protective effect of iron-sheet roofed houses. Malaria Journal. 5(1). 8–8. 85 indexed citations

18.

Ginsburg, H. & Moshe Hoshen. (2002). Is the development of falciparum malaria in the human host limited by the availability of uninfected erythrocytes?. Malaria Journal. 1(1). 18–18. 11 indexed citations

19.

Hoshen, Moshe, Wilfred D. Stein, & H. Ginsburg. (2002). Mathematical modelling of malaria chemotherapy: combining artesunate and mefloquine. Parasitology. 124(1). 9–15. 19 indexed citations

20.

Hoshen, Moshe, R. Heinrich, Wilfred D. Stein, & H. Ginsburg. (2000). Mathematical modelling of the within-host dynamics of Plasmodium falciparum. Parasitology. 121(3). 227–235. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact